As of 2026-02-07, the Relative Valuation of Homology Medicines Inc (FIXX) is (903.31) USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.55 USD, the upside of Homology Medicines Inc based on Relative Valuation is -3779.5%.
The range of the Relative Valuation is (648.01) - (1,229.86) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.2x - 14.5x | 9.9x |
| Forward P/E multiples | 7.6x - 15.3x | 11.4x |
| Fair Price | (648.01) - (1,229.86) | (903.31) |
| Upside | -2739.6% - -5109.6% | -3779.5% |
| Date | P/E |